Teladoc Health, Inc. (NYSE:TDOC) Shares Purchased by Two Sigma Advisers LP

Two Sigma Advisers LP boosted its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 213.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,258,711 shares of the health services provider's stock after purchasing an additional 1,537,094 shares during the period. Two Sigma Advisers LP owned about 1.31% of Teladoc Health worth $20,532,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Arkadios Wealth Advisors bought a new position in shares of Teladoc Health during the 4th quarter valued at about $115,000. Nisa Investment Advisors LLC grew its position in shares of Teladoc Health by 20,936.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock worth $3,874,000 after buying an additional 424,180 shares in the last quarter. Westside Investment Management Inc. increased its position in Teladoc Health by 43.8% during the 4th quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider's stock valued at $84,000 after purchasing an additional 2,800 shares during the period. KBC Group NV increased its holdings in Teladoc Health by 72.3% during the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider's stock valued at $80,000 after buying an additional 3,714 shares during the period. Finally, Robeco Institutional Asset Management B.V. raised its position in shares of Teladoc Health by 21.8% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider's stock worth $6,365,000 after acquiring an additional 125,111 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on TDOC. The Goldman Sachs Group reduced their price target on Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. Wells Fargo & Company lowered their price target on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a report on Thursday, May 8th. Evercore ISI reduced their target price on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating for the company in a research note on Thursday, May 1st. Piper Sandler lowered their price objective on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Finally, Royal Bank of Canada increased their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Twelve analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, Teladoc Health currently has an average rating of "Hold" and an average price target of $9.71.

Insider Activity at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the sale, the insider now owns 64,308 shares of the company's stock, valued at approximately $541,473.36. This represents a 14.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.58% of the stock is currently owned by company insiders.

Teladoc Health Trading Down 1.2%

Shares of TDOC stock traded down $0.09 during trading hours on Friday, hitting $6.82. The company had a trading volume of 4,118,390 shares, compared to its average volume of 6,241,311. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The stock has a market capitalization of $1.20 billion, a PE ratio of -1.18 and a beta of 1.82. The company's fifty day moving average is $7.42 and its 200 day moving average is $9.29. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Research analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.